Podcasts about trials

Join Brian McWilliams, John Odermatt, Lou Perez and Brian Nichols every other week for the newest show on the Lions of Liberty Network, the Politicks Podcast! Each episode we'll dig through the top news stories in the disgusting, slimy political world and of course we'll make you laugh along the way. This week we focus on the "Big, Beautiful Bill", the shooting outside the Israeli embassy in D.C. and Ivanka Trump's odd Jiu Jitsu X posts. Learn more about your ad choices. Visit megaphone.fm/adchoices

"Would I lysine to you?" - Mark Whitacre. Hey that's just a joke but maybe they could have used it on the posters for THE INFORMANT!, Steven Soderbergh's 2009 corporate espionage caper about the lysine price-fixing scandal and one of the weirdest guys there has ever been. And joining us to talk big business, the FBI, and organized crime in all its forms is writer and podcaster Dan O'Sullivan (The Outfit)! Is business run like the mafia or vice versa? Is corruption inherent to capitalism or simply a common side effect? Did Kurt Eichenwald ever go on Twitter? We answer these questions once and for all, so give this one a listen. Further Reading: The Informant: A True Story by Kurt Eichenwald Rats in the Grain: The Dirty Tricks and Trials of Archer Daniels Midland by James B. Lieber Everybody Loves A Good Drought by Palagummi Sainath "Why Capitalism Loves Corruption" by Gareth Fearn Further Viewing: PRIME CUT (Richie, 1972) THE INSIDER (Mann, 1999) ERIN BROCKOVICH (Soderbergh, 2000) MICHAEL CLAYTON (Gilroy, 2007) BURN AFTER READING (Coen, 2008)   Follow Dan O'Sullivan: https://x.com/osullyville https://bsky.app/profile/osullyville.bsky.social https://headgum.com/the-outfit   Follow Pod Casty For Me: https://www.podcastyforme.com/ https://twitter.com/podcastyforme https://www.instagram.com/podcastyforme/ https://www.youtube.com/@podcastyforme Support us on Patreon: https://www.patreon.com/PodCastyForMe Artwork by Jeremy Allison: https://www.instagram.com/jeremyallisonart      

Tim Townsend, author of “Mission at Nuremberg” “Mission at Nuremberg” by Tim Townsend The post A Lutheran Army Chaplain at the Nuremberg War Trials – Tim Townsend, 11/20/24 (3243, Encore) first appeared on Issues, Etc..

Have you ever been under so much pressure you feel completely overwhelmed? Trials and  circumstances can take a toll on us if we allow them to. It's how we respond to difficulties that makes the difference because trials can actually bring out the best in us...or the worst. When we are under pressure or facing challenges, one of the first things to determine is whether the trial was caused from our poor decisions, from the devil, or was it a test from God. Listen as Bill and Annette focus on trials caused by our poor decisions and our lack of knowledge in this podcast episode. For more information about Bill Wiese and Soul Choice Ministries please visit us at: https://soulchoiceministries.org/  You can find more of Bill's teachings at: BillWieseTV-YouTube

When hardships feel endless, remember you can stand unburned—shining as a living example of God's miraculous grace. -------- Thank you for listening! Your support of Joni and Friends helps make this show possible.     Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org   Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

PD and P-Dubs Unscripted dive deep into one of life's hardest questions — why do bad things happen to good people? From Job's suffering to Jesus' promises in Luke 21, PD and P-Dubs explore how faith endures through trials, what it means to trust God when life hurts, and how hardship can actually draw us closer to Christ. Along the way, they share laughs about Chicago weather, sports analogies, and even a Tom Skilling impression — keeping things real, relatable, and rooted in Scripture.Tune in for an honest, hope-filled conversation about suffering, trust, and God's bigger plan.

In this week's nugget we revisit our interview with Carlijn Wagenaar from the Plants for Joints study, as they launch their 'Plants for Health' programme to help those suffering from a range of chronic conditions  - not just joint problems.Order the e-or printed book and sign up for the programme:https://plants-for-health.com/ References for the programme:Two-Year Follow-Up of a Multidisciplinary Lifestyle Intervention for Rheumatoid Arthritis and OsteoarthritisCarlijn A. Wagenaar, Wendy Walrabenstein, Marike van der Leeden et al.Arthritis Care Res (Hoboken), 2025Effect of a multidisciplinary lifestyle intervention on body composition in people with osteoarthritis: Secondary analysis of the “Plants for Joints” randomized controlled trialCarlijn A. Wagenaar, Wendy Walrabenstein, Sofieke C.S. de Jonge et al.Osteoarthritis and Cartilage Open, 2024Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the ‘Plants for Joints' randomised clinical trial Carlijn Wagenaar, Wendy Walrabenstein, Marike van der Leeden, et al.RMD Open, 2024A multidisciplinary lifestyle program for metabolic syndrome-associated osteoarthritis: the ‘Plants for Joints' randomized controlled trialAward: Publication of the yearWendy Walrabenstein, Carlijn Wagenaar, Marieke van de Put, et al.Osteoarthritis and Cartilage, 2023A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints' randomized controlled trialWendy Walrabenstein, Carlijn A Wagenaar, Marike van der Leeden, et al.Rheumatology, 2023The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the “Plants for Joints” randomized controlled trial protocolWendy Walrabenstein, Marike van der Leeden, Peter Weijs, et al.Trials, 2021

Subscribe and Watch on YouTube at Scottish Murders YouTubeWelcome back to another Scotland Then, where we journey through intriguing and sometimes shocking stories from Scotland's past as reported in newspapers.In this episode, Dawn takes us to April and June of 1983, a time marked by notorious crimes, prison scandals, and unexpected accidents. We'll hear of the master key controversy at Dungavel Prison, where an inmate allegedly bribed a prison officer and crafted keys that opened almost every lock. There's also the morbid tale of Catherine Grier's murder, as well as a party that spiralled into violence and culminated in a tragic shooting.Amidst these grim headlines, we get a glimpse into lighter news, such as Edinburgh University's feature in a BBC documentary, and the survival story of a teenager who fell into a 150-foot gully on a rope swing—living to tell the tale. Commenting on the culture and crime of the era, Dawn asks listeners to remember, respond, and share their own experiences.Tune in for an episode packed with real-life drama, and even a few moments of Scottish nostalgia.SOURCES:Please see our website for all source material and photos at https://scottishmurders.com/episodes/johncantsmithBritish Newspaper Archives Affiliate LinkSUPPORT US:Patreon - patreon.com/scottishmurdersKo-fi - ko-fi.com/scottishmurdersMerch - teepublic.com/user/scottishmurdersWebsite - scottishmurders.comTwitter - @scottishmurdersInstagram - @scottishmurderspodcastFacebook - facebook.com/scottishmurdursYouTube - @ScottishMurdersLinktree - linktr.ee/scottishmurdersCREDITS:Scottish Murders is a production of CluarantonnHosted by Dawn YoungResearched, Written and Edited by Dawn YoungProduction Company Name by Granny RobertsonMUSIC:ES_Battle of Aonach Mor - Deskant - epidemicsound

Are you trying to support someone you love without slipping into rescuing, fixing, or doing everything for them? We're diving deep into codependency, emotional boundaries, and what healthy support really looks like when someone you care about is going through a hard season. Join us Monday at 7:30 PM EST for our Live Q and A and get ready to experience healthy relationships God's way! God has timeless truths to help you navigate life and live in freedom as He intended. Join us LIVE on Mondays at 7:30 PM ET where we answer your questions on how to Conquer Codependency God's Way. Do you have a question you would like Aliene to address? We've got you! Just leave your question in the comments below or email questions@treasuredministries.com Don't forget to like, subscribe, and leave a comment if this episode resonates with you! For more information/resources check out the links below: ⇨ Visit the Treasured Ministries Website: https://treasuredministries.com/ ⇨ Join the Treasured Tribe https://treasuredtribe.com/ ⇨ Sign up for our FREE newsletter and get inspiration for your faith journey https://treasuredministries.activehos... ⇨ Donate: https://treasuredministries.com/donate/ ⇨Sign up for retreat https://treasuredministries.com/retreat/ _____________________ Treasured Ministries provides discipleship, biblical resources, and community for women so they can exchange codependency for God dependency and thrive. For more information visit https://treasuredministries.com ______________________ Aliene Thompson is the president of Treasured Ministries International, the creator of the Nourish Bible Study Method, and the founder of the Treasured Tribe, an online Christian community for women. Her popular series on YouTube, "Conquering Codependency God's Way", helps women worldwide move from codependency to God dependency so they can live in freedom as God intended. #codependence #conqueringcodependency

Applying the Actionable Truths 9: RedemptionRedemption. It's what we all want — what we all need — after a crucible. How do we get there — and stay there when in walking out our vision for a life of significance when life gets challenging.That's what we talk about this week. You'll want to pay special attention when we talk about the value of keeping a purple file.To explore Beyond the Crucible resources, including our free Trials-to-Triumphs Self-Assessment, visit beyondthecrucible.com.Enjoy the show? Leave a review on your favorite podcast app and leave a comment at our YouTube channel. And be sure subscribe and tell your friends and family about us.Have a question or comment? Drop us a line at info@beyondthecrucible.com

This week on the show Maine recaps the 2025 ADCC North American trials live from Orlando Florida.  We recap all the divisions starting with the Men'sWe discuss the -66.0 kg Dorian Olivarez-77.0 kg Jacob Bornemann-88.0 kg Jon Blank-99.0 kg Achilles Rocha+99.0 kg Brandon ReedThen  move into the recap of the womens division-55.0 kgAna Mayordomo-65.0 kg Morgan "Mo" Black+65.0 kg Maia MatalonRecorded 11-17-2025

In this episode, we welcome Professor Jonathan Hafetz for an insightful discussion on the complex legal challenges involved in prosecuting individuals accused of mass crimes. Our conversation traces the development of international justice mechanisms from the foundational Nuremberg trials through to contemporary approaches in the age of global terrorism.Professor Hafetz examines how nations have attempted to hold perpetrators accountable while maintaining commitment to fair trial principles - a tension that continues to define international criminal law. The discussion explores the significant impact of the U.S. War on Terrorism on legal frameworks and its disproportionate effects on Arab and Muslim communities.Throughout the episode, we consider how these legal precedents influence current justice systems and what lessons can be drawn from past successes and failures. This thoughtful analysis offers listeners a clearer understanding of the delicate balance between pursuing accountability for grave crimes and preserving fundamental rights protections, even for those accused of the most serious offenses.This episode provides valuable context for anyone interested in international law, human rights, and the ongoing evolution of justice mechanisms in response to atrocities and terrorism.Support the showSupport the Center for Security, Race and Rights by following us and making a donation: Donate: https://give.rutgersfoundation.org/csrr-support/20046.html Subscribe to our Youtube Channel: https://www.youtube.com/playlist?list=PLEbUfYcWGZapBNYvCObiCpp3qtxgH_jFy Follow us on Twitter: https://twitter.com/rucsrr Follow us on Instagram: https://instagram.com/rutgerscsrr Follow us on Threads: https://threads.com/rutgerscsrr Follow us on Facebook: https://facebook.com/rucsrr Follow us on TikTok: https://tiktok.com/rucsrr Subscribe to our Newsletter: https://csrr.rutgers.edu/newsroom/sign-up-for-newsletter/

A new JAMA Internal Medicine study reveals that Trump's NIH funding cuts have abruptly halted nearly 400 clinical trials, leaving more than 74,000 patients — especially those in underserved communities — without essential care and research options. Subscribe to our newsletter to stay informed with the latest news from a leading Black-owned & controlled media company: https://aurn.com/newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you bitter? Unhappy? Has God turned against you? Trials and troubles are never fun, but they give us a chance to be closer to God.

BrainStorm wants to hear from you! Send us a text.The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer's Platform (GAP). A long-time UsA2 advocate, he's been motivated by the generations of family members lost to Alzheimer's and Parkinson's disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts by the Trump Administration, forcing many trial sites to shut down at a time of new FDA-cleared blood tests for early diagnosis.  Dwyer highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities. This must listen episode reinforces clinical trial participation as a valuable care option while advancing research for millions affected by Alzheimer's and related dementias. This episode of BrainStorm is sponsored by Johnson & JohnsonSupport the show

In a live conversation on YouTube, Lawfare Executive Editor Natalie Orpett sat down with Lawfare Senior Editors Anna Bower, Roger Parloff and Eric Columbus and Lawfare Public Service Fellow Loren Voss to discuss an update in the Georgia prosecution of President Trump, a hearing on whether Lindsey Halligan was lawfully appointed as U.S. attorney, a district court barring the deployment of National Guard to Portland, and more.You can find information on legal challenges to Trump administration actions here. And check out Lawfare's new homepage on the litigation, new Bluesky account, and new WITOAD merch.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

Send Us Your Prayer Requests --------This Christmas, you can shine the light of Christ into places of darkness and pain with a purchase from the Joni and Friends Christmas catalog. You are sending hope and practical care to people with disabilities, all in the name of Jesus! Thank you for listening! Your support of Joni and Friends helps make this show possible. Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org. Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

A Prayer for Trials and Training! A prayer led by Pastor Corey Duncan. Join us for our weekly prayer calls on Mondays and Fridays at 7am EST. Dial in at (267) 807-9601 and use code 943334#.

Session 250 of the Land of Israel Fellowship – Chayei Sarah, Faith in Trials & The Struggle for Peace In this week's fellowship, Ari Abramowitz and Jeremy Gimpel dive deep into the Torah portion of Chayei Sarah, exploring its timeless teachings and urgent relevance to the challenges we face in the world today. Ari and Jeremy unpack the story of the death of Sarah, revealing how this moment became yet another profound test for Avraham—a test of faith, resilience, and vision for the future of Israel. We explore how these ancient lessons speak directly to modern times, offering clarity and inspiration for anyone seeking truth, meaning, and connection to the Land of Israel. This session also features a heartfelt dvar Torah by Tehila Gimpel, who illuminates the dramatic relationships between Avraham, Yitzchak, Avimelech, and the wells they fought to preserve. Her insights draw clear parallels between these biblical struggles and the realities we face today as we fight for peace, identity, and spiritual grounding in a turbulent world. If you're seeking uplifting Torah wisdom, Israel-centered inspiration, and teachings that bridge the ancient and the modern, this episode will deeply speak to you. Keywords: Land of Israel Fellowship, Torah portion Chayei Sarah, Ari Abramowitz, Jeremy Gimpel, Tehila Gimpel, dvar Torah, Avraham and Sarah, Isaac and Avimelech, biblical wells, Israel teachings, Jewish inspiration, Torah podcast, faith and trials, modern day Israel, Chayei Sarah insights, Jewish study, Israel spirituality.

------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! questions@eyecode-education.com https://docs.google.com/forms/d/e/1FAIpQLSdEt3AkIpRrfNhieeImiZBF5lYRIR2aAsl7UqWJ_m2GV6OKEA/viewform?usp=header https://coopervision.com/our-company/... Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts  Show Sponsors: CooperVision MacuHealth

Your momentary struggles on earth pale in comparison to the eternal joy God is preparing, so learn to suffer gladly, trusting His perfect plan. -------- Thank you for listening! Your support of Joni and Friends helps make this show possible.     Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org   Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

Gerard Grubb is determined to find the most profitable nitrogen rates for growing corn on his Mildmay, Ont. farm. Grubb says the farm, which has been no-tilled since 2000, has the potential to yield 250 bushels per acre, but he's not chasing the highest yield; he wants to dial in his nitrogen rates to produce... Read More

A Dallas, Texas intersection turned into my holy ground! It was the Light cutting through fog, life breaking into death. In this episode, I share how a near-collision at Midway & Alpha became the moment God moved me from religion to relationship—and how your testimony can do the same in someone else's life. This Godcast moves from story to Scripture to Savior, showing testimony isn't self-spotlight, but God speaking through redeemed lives. Grace doesn't quiet us... it sends us. Not with tales of our Egypt, but with Exodus steps. Not eloquence, but “Jesus Christ, and Him crucified.” Not culture's noise and confusion... but with the living Word, sharp and tender. Now, GO! Testify where He placed your feet on dry ground; not the bondage you left behind, but the freedom He gave you to live in. Then invite someone to that same Deliverer. Today! God's Word: Key passages: John 9; Acts 9; 1 John 5:9–11; Revelation 12:11; plus, Genesis 1, Exodus 25, Psalm 118, Ezekiel 37, Ephesians 2 & 6, Hebrews 4 & 13, and more. You will be able to glean the rest of them from the transcript, amen?Email: walkingtheway3@gmail.com

Pastor Darren continues his current teaching series out of Hebrews 12 giving us a fresh look at how our present trials and situations serve a much greater purpose than just being hardships here on earth, but how these trials are preparing us for something much greater. Thank you for listening to our podcast! We hope you have been encouraged today.Check us out on social media, or to learn more, you can visit our website at www.freedomcanyon.com.

Sermon Date: 11/16/2025; Pastor Bill Bryson; Scripture Passage: John 9:1-28Support the show

Sermon Date: 11/16/2025; Pastor Bill Bryson; Scripture passage: Jude 1:21Support the show

Gratitude is rarely our first instinct when we’re hurting. In today's prayer and devotional, seasons of loss, grief, or overwhelming uncertainty often make thankfulness feel impossible. Keri Eichberger shares the story of her miscarriage nearly 20 years ago—a season filled with deep pain, grief, and a desperate attempt to regain control. Looking back, she realizes how little gratitude she expressed during that time and how much peace she forfeited by striving instead of surrendering. Philippians 4:6-7 reminds us that the pathway to peace is not simply prayer, but prayer with thanksgiving. Gratitude in trials isn’t pretending things aren’t painful; it’s acknowledging God’s presence, goodness, and care—right in the middle of our suffering. Thanksgiving guards our hearts and minds, creating space for the supernatural peace we long for but cannot manufacture on our own. When we thank God—even through tears—we declare by faith that He is working, that He has purpose in our pain, and that His goodness will follow us all the days of our lives. Gratitude doesn’t erase grief, but it anchors us in the truth that God is with us, carrying us, strengthening us, and offering peace the world cannot give. Today's Bible Reading:“Do not be anxious about anything, but in every situation, by prayer and petition, with thanksgiving, present your requests to God. And the peace of God, which transcends all understanding, will guard your hearts and your minds in Christ Jesus.” – Philippians 4:6-7 Takeaway Truths Gratitude is a spiritual discipline that guards our hearts with God’s peace. Peace does not come from control—it comes from surrender. God offers blessings, presence, and purpose even in seasons of deep pain. Let’s Pray Father God, You are my ever-present peace. And though I can become consumed with control, worry, or whatever it is I wish were different, still I know You are there. You are there with perfect peace and boundless blessings, and I am so grateful. Lord, help me acknowledge Your presence. Help me see Your goodness. And help me never forget to express my gratitude to You. You are the giver of all good things; You never stop pouring them out over my life, and I praise You for Your presence and peace that transcend all understanding. In Your Almighty Name, Amen. Related Scriptures 1 Thessalonians 5:18 James 1:2-4 Psalm 34:18 Isaiah 26:3 Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

Today we are talking about chapter 17 of the Sunbearer Trials by Aiden Thomas.The Patreon version of this episode contains ~9 minutes of bonus content about many kinds of delicious food and an epic trip to the zoo. Here's the Storygraph readalong for The Sunbearer TrialsAnd here's the one for Celestial Monsters!Please consider joining our Patreon and/or sticker club! You can now give subscriptions as gifts as well!Find your hosts upon the internet:Check out Lark's art, his website, and his instagramFollow Jessie on instagram and BlueskyFollow the pod on Instagram and Bluesky!Send us your Cozy Corner content here

Free Vs Investment Trials: Why a $1 Trial Can Be More Powerful Than a Free Trial with Favour Obasi-Ike | Sign up for exclusive SEO insights.This Clubhouse audio session focused on marketing strategies, specifically comparing the efficacy of free trials versus investment trials for products and services. Favour discusses how an investment trial, even as low as one dollar, establishes a financial commitment from the customer, potentially leading to better conversion than a completely free offer, though both require nurturing efforts. The conversation also touches on upcoming holiday sales, various email marketing platformslike Flowdesk, and the importance of technical SEO and website development in business growth. Ultimately, Favour advises business owners to analyze and decide which trial method best suits their goals, emphasizing that the psychology of value is crucial for long-term customer engagement.--------------------------------------------------------------------------------Next Steps for Digital Marketing + SEO Services:>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Need SEO Services? Book a Complimentary SEO Discovery Call with Favour Obasi-Ike⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> Visit our Work and PLAY Entertainment website to learn about our digital marketing services.>> Visit our Official website for the best digital marketing, SEO, and AI strategies today!>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join our exclusive SEO Marketing community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> Read SEO Articles>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Need SEO Services? Book a Complimentary SEO Discovery Call with Favour Obasi-Ike⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>> ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to the We Don't PLAY Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠--------------------------------------------------------------------------------Introduction: The "Free Trial" FallacyOffering a "free trial" is a universal business strategy, especially during peak seasons like Black Friday or the holidays. It's the go-to method for attracting customers by lowering the barrier to entry. But have you ever considered that "free" might not be the most effective path to gaining truly committed customers?This article explores a few surprising truths about customer psychology and commitment by comparing the standard free trial with a powerful alternative: the "investment trial." We'll examine why asking for a small, initial investment can fundamentally change the customer relationship and lead to better results.The Surprising Takeaways from Free vs. Investment Trials1. The Power of a Single Dollar: Shifting from a "User" to an "Investor" MindsetThe core difference between a "free trial" and an "investment trial" is the financial commitment. A free trial has none, while an investment trial requires a small payment, even if it's just $1. This seemingly minor detail triggers a significant psychological shift.When a customer pays—even a nominal amount—their mindset changes. They are no longer a passive user getting something for free; they have become an active investor in a potential solution. This act pre-qualifies them and changes their relationship with the product from the very beginning. Because they have invested, they are more likely to perceive the engagement as a "better experience," reinforcing the value of their decision and anticipating an even greater return on a larger future investment....if you now say, okay, it's $99 or it's $1,000 or it's whatever amount of dollars, the person doesn't feel like they have to think twice about started because they've already financially committed to something that was an investment that they were interested in. That's the difference.This initial commitment dramatically shortens the time it takes to convert a trial user into a full-paying customer. The journey from a $1 investment to a $1,000 purchase is psychologically shorter than the journey from "free" to any paid plan. While a free trial may require 14 to 30 days of nurturing to achieve conversion, an investment trial can convert in as little as 10 minutes or one hour because the primary psychological barrier has already been crossed.2. The Real Cost of "Free" Isn't Zero—It's TimeNothing is truly free. In a free trial, the user isn't paying with money, but with an equally valuable currency: their time and attention.When someone engages with a free product, they are spending time processing information and making a decision. The business's goal is to make that time investment feel so valuable that it leads to a financial one. Think of the common B2B strategy of offering a free 30-45 minute consultation call. The prospect invests their time, and in exchange, the business must deliver enough tangible value in that short window to justify a larger investment. The "free" call becomes a sale because the value demonstrated makes the time spent feel worthwhile. The same principle applies to tasting a free food sample—if it delivers immediate value, it leads to a purchase.So if it's a free trial, yes, get it for free. Sign up for free... it's not really free because they're spending time. That's the exchange.The implication for businesses is clear: the product or information offered in a free trial must deliver immediate, tangible value. You must make the user's time investment feel so worthwhile that they are compelled to make a financial one.3. The $2,000 Anomaly: Why High-Ticket Sales Can Be Easier Than Low-Ticket OnesOne of the most surprising claims is that "it's harder for me to sell a $20 product than a $2,000 product." This paradox defies conventional business logic, but the reasoning behind it is sound.Customers often perceive small, recurring payments as nuisances or minor expenses they'd rather avoid. In contrast, they view large, one-time investments as significant projects with a high potential return. A high-ticket investment is tied to a bigger, more valuable outcome—such as achieving AI SEO, building websites, gaining domain authority, or becoming dominant in your area of expertise—that they can justify more easily as a strategic move.This connects directly back to the "investment trial" concept. A person willing to invest just $1 is already thinking about potential returns, which is the exact mindset needed to make a larger, high-value purchase. They have already crossed the mental barrier from being a passive consumer to an active investor.This should encourage you to reconsider your pricing and offer structure. Instead of focusing only on low-cost entry points, consider how to frame your offerings as high-value investments that solve significant problems for your ideal customers.Conclusion: Your Next MoveThe psychology behind a trial offer is often more critical than the price tag. The ultimate goal isn't just to get sign-ups; it's to cultivate an investor's mindset from the very first interaction. By asking for a small commitment, you attract a more serious audience and prime them for a long-term, high-value relationship.As you plan your next offer, ask yourself this: How can you shift the focus from a simple "free sample" to a meaningful "initial investment" to attract your most committed future customers?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if the trial you're facing isn't meant to break you, but to prove that you're ready for the next stage of His promise? In this message, Pastor Aaron Kennedy unpacks the purpose of trials and transitions in the life of a believer. He reminds us that while the enemy uses trials as traps, God uses them as tests designed to promote us, not punish us. Through faith and patience, we learn to trust God's timing and remain anchored in hope even when circumstances are uncertain.

Send us a textCycle CLink to cover Art

Msgr. Roger J. Landry Convent of the Missionaries of Charity, Bronx, NY Thirty-Third Sunday in Ordinary Time, Year C World Day of the Poor November 16, 2025 Mal 3:19-20, Ps 98, 2 Thes 3:7-12, Lk 21:5-19   To listen to an audio recording of this homily, please click below:  https://traffic.libsyn.com/secure/catholicpreaching/11.16.25_MCs_Homily_1.mp3   The following text guided […] The post Persevering With Faith and Hope through Trials, 33rd Sunday (C), November 16, 2025 appeared first on Catholic Preaching.

Featuring: Ammosart, Ashgar, Belghast, Grace, Kodra, Tamrielo, and Thalen   Hey Folks! We recorded a massive show where we effectively burned through our entire backlog of topics.  We start off talking about the new character, Maru, in Destiny Rising, and how this seems to be leading us to finally getting off the planet.  Kodra discusses Broom Sweeper, which is effectively the Roguelikeification of Minesweeper.  Bel got sucked into a local pen and paper game for Public Access and talks a bit about the setting.  Ash is doing a "Three Job Fiesta" run of Trials of Mana, and Tam has been playing some ArcRaiders.  We are all pretty pumped for the announcement of new Steam Hardware and what this means for PC gaming.  Kodra and Tam talk about It Takes a War, and Bel revisits his Freezy Boom character in Path of Exile.  We wrap up the show with some rapid-fire discussions about Gunfire Reborn, Winter Burrow, and Ambrosia Sky.   Topics Discussed: Destiny Rising Pirate Queen Maru Broom Sweeper Public Access TTRPG Trials of Mana Three Job Fiesta Arc Raiders More Steam Hardware It Takes A War Path of Exile Freezy Boom Revisited Gunfire Reborn Winter Burrow Ambrosia Sky

It's World AMR Awareness Week (WAAW) and we have prepared a special episode in light of that. In this week's Communicable, Navaneeth Narayanan and Thomas Tängdén host Aula Abbara (London, UK), Guido Granata (Rome, Italy) and Tuomas Aro (Helsinki, Finland) to discuss the phenomenon of AMR in conflict and crisis zones. They elaborate on how difficult conditions and austere environments amplify the spread of AMR, drawing on findings from the ongoing conflicts in Ukraine, Gaza, Syria and other regions. Other topics covered include adapting antimicrobial stewardship and infection prevention and control (IPC) practices as well as the need for genuine political will and international collaboration to end conflicts and their exacerbation on AMR.This episode follows the webinar “Beyond the frontlines” organised by ESCMID's AMR Action Subcommittee for WAAW 2025, featuring the same guests, and is available on ESCMID Media. This Communicable episode was peer reviewed by Arjana Zerja of Mother Theresa University Hospital Centre, Tirana, Albania.  Related ESCMID and Communicable mediaESCMID Media, Part 1: Beyond the frontlines - tackling AMR in conflict and crisis zones, webinar Communicable episode 11: Nightmare series, part 2 – how to deal with carbapenemase producers Communicable episode 16: Climate change and infections – effects on clinical practice & sustainabilityResourcesTrainee Association of ESCIMD (TAE) Doctors without Borders (Médecins sans Frontières), Antibiogo, https://www.antibiogo.org/Doctors without Borders (Médecins sans Frontières), Mini-lab, https://fondation.msf.fr/en/projects/mini-lab Further ReadingAbbara A, et al. Unravelling the linkages between conflict and antimicrobial resistance. NPJ Antimicrob Resist. 2025. DOI: 10.1038/s44259-025-00099-yAbbara A, et al. A summary and appraisal of existing evidence of antimicrobial resistance in the Syrian conflict. Int J Infect Dis. 2018. DOI: 10.1016/j.ijid.2018.06.010Abu-Shomar R, et al. Multidrug-resistant Pseudomonas isolated from water at primary health care centers in Gaza, Palestine: a cross-sectional study. IJID Reg. 2025. DOI: 10.1016/j.ijregi.2025.100671Aldbis A, et al. The lived experience of patients with conflict associated injuries whose wounds are affected by antimicrobial resistant organisms: a qualitative study from northwest Syria. Confl Health. 2023. DOI: 10.1186/s13031-023-00501-4Aro T, et al. War on antimicrobial resistance: high carriage rates of multidrug-resistant bacteria among war-injured Ukrainian refugees. Clin Microbiol Infect. 2025. DOI: 10.1016/j.cmi.2025.07.010  Bazzi W, et al. Heavy Metal Toxicity in Armed Conflicts Potentiates AMR in A. baumannii by Selecting for Antibiotic and Heavy Metal Co-resistance Mechanisms. Front Microbiol. 2020. DOI: 10.3389/fmicb.2020.00068 Dewachi O. War Biology and Antimicrobial Resistance: The Case of Gaza, AMR Insights, 2024.Granata G, et al. The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review. Clin Microbiol Infect. 2024. DOI: 10.1016/j.cmi.2024.03.029 Huang XZ, et al. Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003-2008. Epidemiol Infect. 2012. DOI: 10.1017/S0950268811002871Hujer KM, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006. DOI: 10.1128/AAC.00778-06Karah N, et al. Teleclinical Microbiology: An Innovative Approach to Providing Web-Enabled Diagnostic Laboratory Services in Syria. Am J Clin Pathol. 2022. DOI: 10.1093/ajcp/aqab160Keen EF 3rd, et al. Evaluation of potential environmental contamination sources for the presence of multidrug-resistant bacteria linked to wound infections in combat casualties. Infect Control Hosp Epidemiol. 2012. DOI: 10.1086/667382Murray CK, et al. Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility. Mil Med. 2009. DOI: 10.7205/milmed-d-03-8008Petersen K, et al. Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center. J Clin Microbiol. 2011. DOI: 10.1128/JCM.00766-10Scott P, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007. DOI: 10.1086/518170Sensenig RA, et al. Longitudinal characterization of Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus colonizing and infecting combat casualties. Am J Infect Control. 2012. DOI: 10.1016/j.ajic.2011.03.025World Health Organization. Fourth WHO Global Evidence Review on Health and Migration stresses that equitable access to and appropriate use of antibiotics for refugees and migrants is essential to tackling Antimicrobial Resistance, News, 2022.

In today's devotional, Dr. Michael A. Youssef calls us to holy devotion of Christ, our righteousness.If you would like more insight into today's devotional topic, listen to Dr. Michael A. Youssef's sermon series Got Freedom?: LISTEN NOW

What if you fall in love on the brink of death? Singing Through Fire (Isaiah 4320 Press, 2025) invites readers into the Job-like true story of a young woman who loses everything-and dares to ask why a good God allows it. When Stanford Law graduate Lara Palanjian collapses on her dream job, she never imagines it will lead to four years bedridden-or to the love of her life. Enter Matthew Silverman: a witty, wise, and impossibly joyful youth pastor and professor facing terminal cancer. What begins with a few random encounters soon ignites an extraordinary, God-written love story that neither of them saw coming. As their unlikely romance unfolds between medical crises, late-night laughter, and unexpected musical performances, Matthew's unshakable faith challenges everything Lara thinks she knows about God's goodness-and what it means to walk with Christlike faith, resilience, and joy in the face of overwhelming grief and suffering. But with time against them, one question looms louder than the rest: What if this gift is only for a moment? Surprisingly funny and spiritually rich, Singing Through Fire is a modern-day "Job meets Lucille Ball." It explores what it means to suffer, love, and even laugh and make music while your life is burning down around you. It eloquently gives voice to the aching questions many sufferers quietly carry-then takes readers inside the breathtaking story of two people who found miraculous love and defiant joy amid heartbreaking loss. It reveals how God can use even our deepest pain to write the most beautiful love stories-even on the cusp of eternity.Find and follow Lara on IG: here Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Do the many clinical trials into high-dose vitamin C prove it can actually treat the common cold and cancer, rather than just boost the immune system? Why is there ongoing scepticism? Why are multifactorial chronic diseases so hard to study in clinical trials? What is the right dosage to get the best results from vitamin C?In this episode we have the often misunderstood topic of Vitamin C as an antioxidant to get clear on, particular the high-dose approach and particularly delivered intravenously. Despite a very clear consensus that Vitamin C is a great booster to immune function, research that shows that it helps fight the common cold or flu have been dismissed by doctors and medical researchers; as well as claims that higher doses can increase its efficacy. Other claims that Vitamin C can help fight cardio-vascular disease and even cancer have been with even greater scepticism. So what exactly can vitamin C do to assist our immune function to fight disease, and why is there so much confusion about the answer given the high quantity of clinical trials data?Fortunately today's guest has exactly the right skill set and research knowledge to separate the science from the here-say, medical doctor and orthomolecular medicine researcher, Dr. Richard Z Cheng. Dr. Cheng has a PhD in biochemistry and molecular biology; he's served as a doctor in the US military; he has consulted for the National Cancer Institute, and presented at the National Institute of Health (NIH); he has conducted clinical trials; He is the editor in Chief of the Orthmolecular Medicine New Service; He is also a fellow of the American Academy of Anti- Aging medicine; and has run anti-aging and regenerative medicine clinics in both China and the US for over 20 years.What we discuss:00:00 Intro05:15 Most animals produce Vitamin C in the body, but not primates.06:00 Oxidation & Redox: Giving or receiving an electron.11:00 After reducing oxidation the body recycles it back into vitamin C.14:00 Teamwork: sharing electrons between nutrients and vitamins.18:20 Conventional consensus: good for prevention but not treatment.21:00 Over 80K papers on Vit C on Pub Med!21:30 Linus Pauling Intravenous Vitamin C for cancer and heart disease.27:00 Shortening of common cold and lowering of symptoms - Harri Hemila.29:00 Low dose studies dilute the data on the efficacy of the high dose studies.31:00 Intravenous treatment allows much higher doses safely.33:00 Differences in absorption between IV and oral application.35:20 Pro-oxidant effect only possible at IV high dose.36:30 IV clinical trials.39:20 Cytokine storm cascades in acute respiratory distress.44:00 High Dose IV Vitamin C saved lives in China during Covid 19.50:00 Attacks following Richard's NIH presentation on Vitamin C during covid.57:00 Cardio vascular disease - Vit. C research history.01:01:00 Collagen Synthesis for vascular walls & Vitamin C deficiency.01:07:20 Is the taboo for life style medicine lifting?01:09:30 Issues of gold standard RCT trials not working for multifactorial integrative interventions.01:16:00 Recommendations for preventative use of Vitamin C for listeners. References:E Cameron & Linus Pauling - 'Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer', 1976E.T. Creagan, 'Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer', 1979Harri Hemilä - over 200 meta-analyses and clinical trialsPing Chen et al. 'Pharmacokinetic Evaluation of Intravenous Vitamin C'Richard Z Cheng, ‘Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?'KU Cancer Center researchers announce study of high-dose intravenous vitamin C to treat muscle-invasive bladder cancer, 2024National Cancer Institute overview of IV Vitamin C cancer research.

Would this be described as a difficult time for you? Maybe you're one of the many who is really struggling financially right now? Or perhaps your marriage is falling apart or you're really discouraged about what's going on in the world around you! When times are tough, the book of First Peter is a good place to turn for hope and encouragement. And that's where we're headed today and in the coming weeks on a Daily Walk. Trials are a part of life, and something we all encounter. We'll show you how to go through them, while maintaining a godly perspective! To support this ministry financially, visit: https://www.oneplace.com/donate/1368/29?v=20251111

Standing Firm on a Shaky World -Rejoicing in Trials - 1Peter 4:12-19

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Curtis Green, better knows by OG bitcoiners as "Chronicpain" or "Flush", is a former forum moderator and website administrator of the Silk Road internet marketplace. He is a man who has mined bitcoin early enough to get scammed by Butterfly Labs, and was allegedly also the target of a bounty on assassination markets. He's seen all eras of Bitcoin, and today he seeks to get pardoned by the Trump administration. He will accept donations from community members in order to get the legal help he needs. Read Curtis Green's book, "Silk Road Takedown": https://www.amazon.com/dp/1729436889 Donate to Curtis Green: https://www.satlantis.io/events/1210/Evening-with-OG-Curtis-Green%2C-admin-of-The-Silk-Road Time stamps: 00:01:18 Welcome Curtis Green, Silk Road OG 00:02:06 Seeking Clemency, Focus Shift from Ross 00:04:02 Misnomers, Site Rules & Govt Narrative 00:07:27 Bitcoin Skepticism, Forum Learning 00:11:02 PGP/Key Lessons 00:13:04 Harm Reduction Suggestion, Forum Admin 00:15:23 Freedom Emphasis, Site Growth Post-Schumer 00:17:00 Bitcoin as Freedom Tool 00:21:36 Verify Mindset 00:22:59 Mining & Gifting BTC, Family Rejection 00:26:01 Price Doubts, Ethereum Shift 00:29:02 Arrest Warning 00:33:40 Mining Fun 00:36:02 When Schumer Promoted Silk Road 00:38:17 Arrest Story, Corrupt Agents 00:39:55 BTC Theft by Shaun ridges 00:43:04 Faked Torture, Murder Threat 00:45:04 Playing Dead for 10 Months 00:48:03 Narrative Control, Cash Seizure 00:51:21 Limited DPR Info, Accusations 00:53:28 Site Takedown, Personal Hell 00:55:00 Family Struggles, Entrepreneurship 00:57:12 Book & Documentary Distortions 00:59:45 Corrupt Agents' Trials 01:02:30 Force's Extortion Attempts 01:05:15 Bridges' Theft Details 01:07:50 Sentencing, No Prison 01:10:20 Clemency Petition 01:13:45 Bitcoin Evolution Reflections 01:16:10 Mining Zcash, Privacy Views 01:19:30 Early Bitcoin Doubts 01:22:45 Forum Discussions, Community 01:25:00 Harm Reduction Impact 01:27:30 Global Revolution Hopes 01:32:03 Consensus & Debates 01:34:02 Aha Moments 01:39:01 Narrative Shaping Power 01:41:23 Life Experiences Gratitude 01:43:37 Speaking Out, Misjudgments 01:45:03 Educating on Crypto Choices 01:46:00 Future Optimism 01:47:32 Educators like Antonopoulos 01:49:52 Community Support Moments 01:52:07 Bitcoin Changes Narrative 01:53:02 Lightning Node Experience 01:55:55 Lightning Hopes & Issues 01:57:05 Wrapped BTC Concerns 01:59:14 WBTC on Ethereum Popularity 02:00:14 Block Size Debates 02:02:07 Satoshi's Scaling Views 02:04:33 Lightning Limitations 02:06:00 Scaling Consensus Challenges 02:08:44 Roger Ver's Unity Point 02:10:10 Early Empty Blocks 02:12:04 Zcash Proposal for Bitcoin 02:14:03 Sponsors: NoOnes & SideShift 02:16:42 ShapeShift Confusion 02:18:00 Tunnel Vision on BTC Amounts 02:18:07 Bitcoin Changes & Consensus Hopes 02:18:30 ETFs Caution, Mainstream Adoption 02:19:33 Peer-to-Peer Origins, Early Exchanges 02:20:05 Postal Money Orders for BTC 02:21:02 Alpaca Socks & Honey Purchases 02:21:49 Early BTC Buys, Galaxy Tab Scam 02:23:15 BTC as Tool, Not Dollars 02:24:01 Holding vs Spending 02:26:00 Early Satoshi Discussions 02:27:27 Adoption Decline Rant 02:28:22 BTC Scarcity & Usage 02:29:03 Layer 2 Hopes, Wife's Worries 02:30:05 Mining Challenges Over Time 02:31:03 Still Early in Bitcoin? 02:32:25 Satoshi's Blueprint, Competition 02:33:30 First Bitcoin Encounter 02:34:51 Silk Road Catalyst for BTC 02:35:25 Rabbit Hole Journey 02:36:31 Govt Op Doubts Nixed 02:37:02 Aha Moment in 2012 02:38:00 Grateful for Silk Road Lessons 02:39:02 Bad Rap Focus on Drugs 02:40:47 Pinnacle in BTC History 02:41:29 Speaking Out & Education 02:42:03 DPR's Clean Water Ideas 02:43:00 Zcash Mining Hype & Launch Supply Dynamics 02:45:01 Keeping ZEC, Mining Costs 02:46:09 Buying vs Mining Regrets 02:47:11 Hindsight on Holding 02:48:31 ASIC Delivery Post-Arrest 02:49:03 Keeping Quiet on Miners 02:50:07 Side Stories Justification 02:51:03 Mentality Shifts 02:52:17 Hopes for Bitcoin Win 02:53:01 Cultural vs Technical Issues 02:53:46 SegWit & Taproot Changes 02:55:38 Privacy Proposals 02:57:01 Developer Frustrations 02:58:04 Greed & Humanity Balance 02:59:20 Year-by-Year Changes 03:00:04 ETF as Scaling Layer 03:02:05 High Hopes & 21M Cap Worries 03:03:05 Verification Defeat 04:03:30 Genesis Block & Bailouts 04:04:03 Fractional Reserves Drop 04:04:38 ETF Trust Issues 04:04:52 Proof of Keys Celebration 04:05:55 Back to Banks Cycle 04:06:07 Lightning Custodial Wallets & Centralization 04:14:02 Start9 & Braiins BMM Miner 04:18:02 Home Miners Appeal 04:49:44 Guilty Plea Frustrations 04:51:18 AlphaBay Documentary & Monero Adoption 04:52:48 Dark Web Warnings 04:55:32 Trusted Escrows 04:56:47 Bitcoin Talk Scams 04:57:13 Satlantis Donations & Adopting Bitcoin Talk

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "NEALS 2025: Takeaways That Matter for ALS Care," ALS experts Jinsy Andrews, MD, MSc, and James Berry, MD, MPH, reflect on key themes from the 2025 NEALS Annual Meeting, now reintroduced as the Network of Excellence for ALS. They discuss format changes that elevated lightning science, the expanding gene therapy pipeline, and a growing slate of NEALS-affiliated trials. The conversation highlights updates from the HEALEY Platform Trial, the MY-MATCH biomarker-guided precision trial, SOD1 program data, and new antisense and viral vector therapies aimed at sporadic ALS. They also explore the impact of Act for ALS on trial access, the ALL ALS biospecimen repository, and NIH-supported expanded access cohorts. The discussion closes with insights on combination therapy strategies, genetic subtypes, presymptomatic enrollment, and how new collaborations, digital endpoints, and infrastructure advances are shaping momentum heading into 2026. Looking for more Neuromuscular discussion? Check out the NeurologyLive® Neuromuscular clinical focus page. Episode Breakdown: 1:05 – Reflections on meeting highlights and NEALS rebranding into a global network 5:00 – Notable NEALS-affiliated trials and promising new mechanisms in ALS care 12:45 – Combination therapy strategies and future approaches in ALS research 15:20 – Neurology News Minute 18:00 – Expanding clinical trial access for rare and genetic ALS subtypes 22:10 – Building momentum and expectations for the 2026 NEALS Annual Meeting The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency Supplemental New Drug Application Submitted for AXS-05 as Treatment for Alzheimer Disease Agitation BTK Inhibitor Fenebrutinib Meets Primary End Points in Phase 3 Trials for Both Relapsing and Primary Progressive MS  Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Summary In this engaging conversation, Pastor Jackson Lahmeyer shares his remarkable journey from a young pastor to a prominent figure in the political and faith communities. He discusses the challenges he faced during the pandemic, his advocacy for religious freedom, and the importance of finding true happiness amidst trials. Lahmeyer also provides insights into the newly established White House Faith Office and its role in protecting religious liberty and empowering faith-based organizations. The conversation delves into the ongoing spiritual battle between good and evil and reflects on the future of faith in America.In this conversation, Jackson Lahmeyer discusses the biblical prophecies surrounding the end times, including the Great Tribulation, the return of Jesus Christ, and the significance of the Third Temple in Jerusalem. He emphasizes the importance of understanding these events from a Christian perspective, the role of the Antichrist, and the implications for both Jews and Christians. The discussion also touches on America's support for Israel and the moral complexities of prophecy fulfillment.Jackson's LinkNEW BOOK: Chasing After The WindClayton's Social Media LinkTree | TikTok | Instagram | Twitter (X) | YouTube | RumbleTimecodes 00:00 - Intro01:01 - Pastor Jackson Laemeyer's Journey into Politics06:30 - Finding Happiness in Trials and Tribulations14:45 - The Role of the White House Faith Office20:41 - Interfaith Dynamics and Religious Liberty26:45 - The Spiritual War: Light vs. Darkness31:08 - The Vision of New Heaven and New Earth35:09 - Understanding the Great Tribulation39:38 - The Role of the Antichrist47:59 - Support for Israel and Biblical ProphecyIntro/Outro Music Producer: Don Kin IG: https://www.instagram.com/donkinmusic/Spotify: https://open.spotify.com/artist/44QKqKsd81oJEBKffwdFfPSuper grateful for this guy ^NEWSLETTER - SIGN UP HEREBecome a supporter of this podcast: https://www.spreaker.com/podcast/traveling-to-consciousness-with-clayton-cuteri--6765271/support.

What if the very trial you're walking through is the place where God plans to reveal His deepest work in you? In this message, Trials of Suffering, Pastor Michael Chandler continues the Set Apart series by exploring how God transforms our pain into purpose. This message invites listeners to see suffering not as a setback, but as sacred ground where faith, healing, and maturity are formed.

As America approaches 250 years, Kevin Freeman and Mike Carter link modern geopolitical and economic risks with themes from Revelation to highlight six urgent “trials by fire.” From the national debt bomb and currency challenges to CBDCs, inflation-driven wealth gaps, demographic decline, and immigration without assimilation, the stakes are high but manageable. They propose constitutional and market-based solutions, including transactional gold and silver (“Pirate Money”), investor alignment, and proactive civic engagement. A neutral, data-driven framework helps assess threats, prepare wisely, and bolster American resilience.

Reach Out: Please include your email and I will get back to you. Thanks!Good morning! Thank you for taking a few minutes to listen. If you are interested in the Daily Bible Devotional, you can find it at the links below:Amazon - (paperback, hardcover, and Kindle)YouTube Video Introducing the ContentFeel free to reach out with any questions: emersonk78@me.comI Peter 1Peter writes to believers scattered across the regions, reminding them of their living hope through the resurrection of Jesus Christ. He praises God for granting an inheritance that is imperishable, undefiled, and reserved in heaven. Trials and suffering are depicted as means to refine faith, which is more precious than gold. Peter emphasizes that salvation has been foretold by the prophets and revealed through Christ. He urges believers to live holy lives, fully setting their hope on the grace to come. As obedient children, they are called to be distinct from the world and to live in reverent fear, knowing they were redeemed by the precious blood of Christ. Peter reminds them that the will of God endures forever and that they have been born again through the living Word.  We are reminded in this passage that our hope is not rooted in anything temporary but in the resurrection of Jesus Christ. Because of this, we can face trials with confidence, knowing that God uses them to strengthen and refine our faith. We are called to live holy and obedient lives, setting ourselves apart from the world and keeping our eyes on the eternal inheritance that awaits us. As we reflect on the cost of our redemption, we are inspired to live in reverent awe of God. We have been born again through His living and enduring Word, and we now have a purpose to live differently. Each day, we strive to reflect His holiness in our thoughts and actions. Gracious Lord, thank You for a living hope through the resurrection of Jesus Christ. We praise You for the inheritance that is kept in heaven for us, pure and everlasting. Help us remain strong through trials, knowing that our faith is being refined and made more precious than gold. Teach us to live holy lives, set apart for Your glory. May we walk in reverent fear, always remembering the great price You paid for our redemption. Let Your Word grow in our hearts and guide our steps daily. Strengthen us to live in obedience and to love one another sincerely. Thought Questions: What has God's mercy and power accomplished for you? Specifically, what is the promised “inheritance”, and how does it guide your life? How do you “prepare your mind for action, keep sober in spirit, and fix your hope completely” on Christ's return on a daily basis? Why is the love of brethren such a central part of living the Word and honoring the sacrifice of Jesus? How do you do this when it is difficult?

In a live conversation on YouTube, Lawfare Editor in Chief Benjamin Wittes sat down with Lawfare Senior Editors Anna Bower, Molly Roberts, Roger Parloff and Eric Columbus to discuss the criminal trial of the man who threw a sandwich at a federal immigration officer in D.C., a hearing in the prosecution of James Comey, litigation over the conditions of an immigration detention center in Illinois, and more.You can find information on legal challenges to Trump administration actions here. And check out Lawfare's new homepage on the litigation, new Bluesky account, and new WITOAD merch.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.